# Drug-Response-Prediction-for-Pancreatic-Cancer-using-Multiomics-profiling
Pancreatic cancer's challenges demand understanding drug responses. AI prediction improves outcomes, cuts costs. Integrating descriptors and cell features, this study achieves 89% accuracy with Tabnet. Identified common scaffolds for high IC50 drug clusters.
